Dr. Reddy’s Laboratories Ltd (RDY) has released an update.
Dr. Reddy’s Laboratories Ltd. has announced a Board of Directors meeting scheduled for May 7, 2024, to approve financial results for the quarter and fiscal year ending March 31, 2024, and to consider declaring a dividend for the fiscal year 2023-24. Additionally, they have notified the closure of the trading window from March 25, 2024, to May 9, 2024, to comply with insider trading regulations.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
